Cargando…
New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme
Glioblastoma multiforme (GBM) is known as the most aggressive and prevalent brain tumor with a high mortality rate. It is reported in people who are as young as 10 years old to as old as over 70 years old, exhibiting inter and intra tumor heterogeneity. There are several genomic and proteomic invest...
Autores principales: | Singh, Manisha, Jindal, Divya, Agarwal, Vinayak, Pathak, Deepanshi, Sharma, Mansi, Pancham, Pranav, Mani, Shalini, Rachana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834280/ https://www.ncbi.nlm.nih.gov/pubmed/36654821 http://dx.doi.org/10.37349/etat.2022.00118 |
Ejemplares similares
-
Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools
por: Singh, Manisha, et al.
Publicado: (2023) -
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
por: Brar, Harpinder K., et al.
Publicado: (2022) -
Neuroprotective Ability of Apocynin Loaded Nanoparticles (APO-NPs) as NADPH Oxidase (NOX)-Mediated ROS Modulator for Hydrogen Peroxide-Induced Oxidative Neuronal Injuries
por: Singh, Manisha, et al.
Publicado: (2021) -
Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
por: Behl, Tapan, et al.
Publicado: (2021) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)